GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ConvaTec Group PLC (LSE:CTEC) » Definitions » Price-to-Owner-Earnings

ConvaTec Group (LSE:CTEC) Price-to-Owner-Earnings : 25.05 (As of Apr. 26, 2024)


View and export this data going back to 2016. Start your Free Trial

What is ConvaTec Group Price-to-Owner-Earnings?

As of today (2024-04-26), ConvaTec Group's share price is £2.756. ConvaTec Group's Owner Earnings per Share (TTM) ended in Dec. 2023 was £0.11. It's Price-to-Owner-Earnings for today is 25.05.


The historical rank and industry rank for ConvaTec Group's Price-to-Owner-Earnings or its related term are showing as below:

LSE:CTEC' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 8.91   Med: 21.2   Max: 39.97
Current: 25.23

During the past 11 years, the highest Price-to-Owner-Earnings of ConvaTec Group was 39.97. The lowest was 8.91. And the median was 21.20.


LSE:CTEC's Price-to-Owner-Earnings is ranked better than
58.36% of 281 companies
in the Medical Devices & Instruments industry
Industry Median: 32.43 vs LSE:CTEC: 25.23

As of today (2024-04-26), ConvaTec Group's share price is £2.756. ConvaTec Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was £0.05. Therefore, ConvaTec Group's PE Ratio for today is 56.24.

As of today (2024-04-26), ConvaTec Group's share price is £2.756. ConvaTec Group's EPS without NRI for the trailing twelve months (TTM) ended in was £0.11. Therefore, ConvaTec Group's PE Ratio without NRI for today is 26.00.

During the past 11 years, ConvaTec Group's highest PE Ratio without NRI was 37.16. The lowest was 9.41. And the median was 21.83.


ConvaTec Group Price-to-Owner-Earnings Historical Data

The historical data trend for ConvaTec Group's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ConvaTec Group Price-to-Owner-Earnings Chart

ConvaTec Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.05 14.87 19.71 37.52 21.80

ConvaTec Group Semi-Annual Data
Dec13 Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.71 - 37.52 - 21.80

Competitive Comparison of ConvaTec Group's Price-to-Owner-Earnings

For the Medical Instruments & Supplies subindustry, ConvaTec Group's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ConvaTec Group's Price-to-Owner-Earnings Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ConvaTec Group's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where ConvaTec Group's Price-to-Owner-Earnings falls into.



ConvaTec Group Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

ConvaTec Group's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=2.756/0.11
=25.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ConvaTec Group  (LSE:CTEC) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


ConvaTec Group Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of ConvaTec Group's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


ConvaTec Group (LSE:CTEC) Business Description

Traded in Other Exchanges
Address
23 Forbury Road, 3 Forbury Place, Reading, GBR, RG1 3JH
Originally spun out of Bristol-Myers Squibb, Convatec designs, manufactures, and markets advanced wound care, ostomy, continence care, and infusion sets for the acute-care hospital and chronic-care home settings. Advanced wound care and continence care are the largest divisions, accounting for 30% and 26% of total revenue, respectively. Ostomy contributes 25% of revenue and infusion sets 19%.

ConvaTec Group (LSE:CTEC) Headlines